Annual General Meeting of Shareholders May 13, 2008 1 - PowerPoint PPT Presentation

Annual General Meeting of Shareholders May 13, 2008 1

• Registration of the quorum Registration of the quorum • Composition of the ‘bureau’ Composition of the ‘bureau’ 2

Agenda Agenda : 1. 1. Reading, deliberating and commenting of the annual report of Reading, deliberating and commenting of the annual report of the board of directors and the statutory auditor’s report on the the board of directors and the statutory auditor’s report on the annual accounts for the accounting year 2007. annual accounts for the accounting year 2007. 3

Report of the board Report of the board of directors for 2007 of directors for 2007 Ger van Jeveren Ger van Jeveren Jan Peeters Jan Peeters CEO CEO CFO CFO 4

Key facts 2007 Key facts 2007 • Turnover + Turnover +10 10%, of which %, of which 6% organic (compared to % organic (compared to 2006 2006) • Net profit + Net profit +34 34% (compared to % (compared to 2006 2006) • Very successful Initial Public Offering (‘IPO’) of Arseus, approx. Very successful Initial Public Offering (‘IPO’) of Arseus, approx. 2 2 times oversubscribed times oversubscribed • Acquisition of Polichimica, an Italian company which achieved a Acquisition of Polichimica, an Italian company which achieved a turnover of turnover of € 10 10 million in million in 2006 2006 • All commercial and logistic services located in Belgium were All commercial and logistic services located in Belgium were centralized in Waregem centralized in Waregem • Further integration of Eurotec and Besserat (both acquired in 2006 Further integration of Eurotec and Besserat (both acquired in 2006) 5

Sales per quarter Sales per quarter 2006 2006 - 2007 2007 - 2008 2008 Quarterly Sales Breakdown 2006 Quarterly Sales Breakdown 2006- -2007 2007-2008 2008 100 90.3 82.2 7.9 80.0 80 74.7 6.9 6.2 13.1 71.1 68.4 67.4 6.3 65.5 11.2 13.7 6.1 61.8 6.3 6.3 6.4 12.8 s (€m) 60 12.0 5.7 10.7 11.6 11.5 11.5 Sales ( 35.9 35.9 11.4 31.3 34.3 29.0 40 28.8 24.6 26.1 24.5 22.7 20 33.4 31.3 26.6 27.3 25.9 24.2 24.3 23.1 22.0 0 2006 2007 2008 2006 2007 2006 2007 2006 2007 �� �� �� �� Fagron Group Dental Medical Corilus 6

Arseus sales long term trend indicator Arseus sales long term trend indicator MAT Sales 2007 MAT Sales 2007 112 110 108 106 104 104 102 100 98 96 94 jan- feb- mrt- apr- mei- jun- jul- aug- sep- okt- nov- dec- jan- feb- mrt- apr- mei- jun- jul- aug- sep- okt- nov- dec- jan- feb- mrt- apr- mei- jun- jul- aug- sep- okt- nov- dec- 05 05 05 05 05 05 05 05 05 05 05 05 06 06 06 06 06 06 06 06 06 06 06 06 07 07 07 07 07 07 07 07 07 07 07 07 7

REBITDA REBITDA Strong performance in all divisions Strong performance in all divisions � �� � Corilus ���� ������ Medical ��� Dental ��� ������� �� ���� ���� ��� ��� Fagron ����� ���� ��� ���� ���� ���� ���� 8

Compelling growth strategy Compelling growth strategy Sustainable long Sustainable long- -term growth term growth ���!�" ���!� ���!� ���!�" "#�$%!� "#�$%!� #�$%!� #�$%!� �*!��+')��$� �*!��+')��$� �*!��+')��$� �*!��+')��$� �%& �%&" �%& �%&" "��� "��� ���" ���" "�%'$�� "�%'$�� �%'$�� �%'$�� (��" (�� (��" (�� "�%�)*!��� "�%�)*!��� �%�)*!��� �%�)*!��� ��������� ��������� ��������� ��������� )$%+')� )$%+')� !.-!$$!�-! !.-!$$!�-! +��+!,& +��+!,& *�! !�-! *�! !�-! • New ERP New ERP • 2006 Acquisition 2006 Acquisition • The Netherlands The Netherlands • • Fagron (A Fagron (A- -brand) brand) • Concept selling Concept selling implementations implementations Eurotec & Eurotec & • France France • Corilus • Corilus • Arseus Tec Arseus Tec • WMS WMS Besserat Besserat • Germany Germany • Greenock • Greenock • Compounding Compounding • Central purchasing Central purchasing • 2007 Acquisition 2007 Acquisition • Spain Spain • Baltes • Baltes services services • Cost control Cost control Polìchimica Polìchimica • Italy Italy • • Cinnaber Cinnaber • Total helpdesk Total helpdesk • 2008 Acquisition 2008 Acquisition • United Kingdom United Kingdom • CEKA / Preci • CEKA / Preci- -line line services services Julie Julie- -Owandy Owandy • Switzerland Switzerland • • Texa Texa • 2008 Acquisition 2008 Acquisition • Czech Republic Czech Republic • • DermaVital DermaVital Tamda Tamda • Portugal Portugal • Luxembourg Luxembourg • Austia Austia 9

Operations Arseus in Europe Operations Arseus in Europe In In 2007 2007 Arseus already had operations in Arseus already had operations in Belgium, The Netherlands, France, Belgium, The Netherlands, France, Germany, Spain, Italy, the United Kingdom Germany, Spain, Italy, the United Kingdom and Switzerland. It also markets its products and Switzerland. It also markets its products and Switzerland. It also markets its products and Switzerland. It also markets its products in Austria, Luxembourg and Portugal. in Austria, Luxembourg and Portugal. Due to the acquisition in Due to the acquisition in 2008 2008 of Czech of Czech based Tamda, Arseus started operations in based Tamda, Arseus started operations in Central and Eastern Europe. Central and Eastern Europe. 10 10

Arseus Divisions Arseus Divisions focus on adding value focus on adding value Arseus is currently focused on four market segments… Arseus is currently focused on four market segments… Pharmaceutical compounding Pharmaceutical compounding products and services products and services Dental products and services Dental products and services Medical products and services Medical products and services Healthcare IT solutions Healthcare IT solutions … to to achieve operational synergies through the integration of back offices and share achieve operational synergies through the integration of back offices and share best practices, market intelligence and customer insight as key differentiator best practices, market intelligence and customer insight as key differentiator towards suppliers towards suppliers 11 11

One One-stop stop-shop for shop for pharmaceutical pharmaceutical pharmaceutical pharmaceutical compounding compounding FY FY–07 Sales 07 Sales FY FY–07 EBITDA 07 EBITDA ��� ��� 12 12

Fagron Fagron - leading the market and well leading the market and well positioned for growth positioned for growth Market Position Competitive Strengths • • The only European The only European Highest brand recognition Highest brand recognition player player • Focus on total integrated Focus on total integrated • The only European The only European solutions solutions ��!" +)*" /)*� 0)�� 0)�� brand brand brand brand • */��1�-!%+'-�$� Extensive product range Extensive product range • -)1*)%��'�, Large experienced Large experienced • Superior quality Superior quality sales force (160 reps) sales force (160 reps) • • Partner of choice for Partner of choice for Centralised purchasing Centralised purchasing pharmaceutical industry pharmaceutical industry Fagron’s strategy is to expand its European presence, Fagron’s strategy is to expand its European presence, strengthen the Fagron brand, and continue to launch strengthen the Fagron brand, and continue to launch innovative products and services innovative products and services 13 13

Fagron: sustainable profitability Fagron: sustainable profitability Sales (in € m) • Strong sales growth supported by: Strong sales growth supported by: 125 110.0 96.7 � � 100 New own product launches New own product launches +14% +14% 75 59.1 � � 49.2 Innovative concepts Innovative concepts 50 +20% +20% 25 � � Strong performance in Industry Strong performance in Industry 0 department department department department S2 2006 S2 2007 FY 2006 FY 2007 REBITDA (in € m) • 25 Sustainable REBITDA growth Sustainable REBITDA growth 20.3 20 17.6 +15% +15% 15 11.0 9.2 10 +20% +20% 5 0 S2 2006 S2 2007 FY 2006 FY 2007 14 14

One One-stop stop-shop for shop for dental professionals dental professionals FY FY–07 Sales 07 Sales FY FY–07 EBITDA 07 EBITDA ��� ��� 15 15